Assessment and Treatment of Patients with ME/CFS: Clinical Guidelines for Psychiatrists. Eleanor Stein, MD, FRCPC. 2005. This guide explains differences between CFS/ME and mental disorder symptoms, and provides guidelines for helping patients cope with CFS/ME.
http://sacfs.asn.au/download/guidelines_psychiatrists.pdf
that should answer your questions about what ME/CFS patients need from mental health professionals and what sort of cognitive therapy can be beneficial
the remainder explain the diseases of ME/CFS and FM (which, despite your diagnosis--probably a misdiagnosis--of ME, I think you may be confusing with the symptom of chronic fatigue which can be caused by many different things... of course, this is a very normal thing to do--even the health authorities confuse the symptom and the disease. But, now you know better.
)
Carruthers, et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols. J CFS 2003. 11(1)
http://www.co-cure.org/ccpccd.pdf
Brown MM, Brown AA, Jason LA. "Illness duration and coping style in chronic fatigue syndrome." Psychol Rep. 2010 Apr;106(2):383-93. PMID:
20524538
Christodoulou, Deluca, Johnson, Lange, et al. Examination of Cloningers Basic Dimensions of Personality in Fatiguing Illness: Chronic Fatigue Syndrome and Multiple Sclerosis. J Psychosom Res. 1999 Dec;47(6):597-607. PMID:
10661606
Taylor RR, Jason LA. "Sexual abuse, physical abuse, chronic fatigue, and chronic fatigue syndrome: a community-based study." J Nerv Ment Dis. 2001 Oct;189(10):709-15. PMID:
11708672
Fossey et al. "Sleep quality and psychological adjustment in chronic fatigue syndrome." J Behav Med. 2004 Dec;27(6):581-605. PMID:
15669445
Maes M, Twisk FN. "Chronic fatigue syndrome: Harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways." BMC Med. 2010 Jun 15;8:35. PMID:
20550693
Hooper M. "Myalgic encephalomyelitis: a review with emphasis on key findings in biomedical research." J Clin Pathol. 2007 May; 60(5): 466-471.
PMC1994528
Fletcher MA, Zeng XR, Maher K, et al. "Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26." PLoS One. 2010 May 25;5(5):e10817. PMID:
20520837
Peckerman A, LaManca JJ, Dahl KA, Chemitiganti R, Qureishi B, Natelson BH. "Abnormal impedance cardiography predicts symptom severity in chronic fatigue syndrome." Am J Med Sci. 2003 Aug;326(2):55-60. PMID:
12920435
The ones with post-exertional malaise are the ones with ME/CFS. The others have chronic fatigue for some other reason.
Kogelnik AM, Loomis K, Hoegh-Petersen M, Rosso F, Hischier C, Montoya JG. "Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue." J Clin Virol. 2006 Dec;37 Suppl 1:S33-8. PMID:
17276366
Light AR, Bateman L, Jo D, Hughen RW, Vanhaitsma TA, White AT, Light KC. "Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome, and Fibromyalgia Syndrome." J Intern Med. 2011 May 26. doi: 10.1111/j.1365-2796.2011.02405.x. [Epub ahead of print] PMID:
21615807
Nicolson GL, Gan R, Haier J. "Multiple co-infections (Mycoplasma, Chlamydia, human herpes virus-6) in blood of chronic fatigue syndrome patients: association with signs and symptoms." APMIS. 2003 May;111(5):557-66. PMID:
12887507
VanNess MJ, Snell CF, Stevens SR. "Diminished Cardiopulmonary Capacity During Post-Exertional Malaise." J CFS Vol 14(2) 2007. haworthpress.com doi:10.1300/J092v14n02_07
Reduced functional capacity and post-exertional malaise following physical activity are hallmark symptoms of Chronic Fatigue Syndrome (CFS). That these symptoms are often delayed may explain the equivocal results from clinical cardiopulmonary exercise testing with CFS patients. ... For test 2 the CFS patients achieved significantly lower values for both VO2 peak and AT (anaerobic threshold). ... A second test may be necessary to document the atypical recovery response and protracted malaise unique to CFS.
Schutzer SE, Angel TE, Liu T, Schepmoes AA, Clauss TR, Adkins JN, Camp DG, Holland BK, Bergquist J, Coyle PK, Smith RD, Fallon BA, Natelson BH. "Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome." PLoS One. 2011 Feb 23;6(2):e17287. PMID:
21383843
Streeten DH, Anderson GH Jr. "The role of delayed orthostatic hypotension in the pathogenesis of chronic fatigue." Clin Auton Res. 1998 Apr;8(2):119-24. PMID: 9613802
Sheedy JR, Wettenhall RE, Scanlon D, Gooley PR, Lewis DP, McGregor N, De Meirleir KL, et al. "Increased d-lactic Acid intestinal bacteria in patients with chronic fatigue syndrome." In Vivo. 2009 Jul-Aug;23(4):621-8. PMID: 19567398
Lerner AM, Lawrie C, Dworkin HJ. Repetitively negative changing T-waves at 24-h electrocardiographic monitors in patients with the chronic fatigue syndrome (left ventricular dysfunction in a cohort). Chest. 1993; 104:1417-1421. PMID: 8222798
Kerr JR, Komaroff AL, Chia JK., et al. "Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome/myalgic encephalomyelitis." J Gen Virol. 2010 Apr;91(Pt 4):893-7. PMID: 20007355
Jammes Y, Steinberg JG, Mambrini O, Brgeon F, Delliaux S. "Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise." J Intern Med. 2005 Mar;257(3):299-310. PMID: 15715687
Whistler T, Jones JF, Unger ER, Vernon SD. "Exercise responsive genes measured in peripheral blood of women with chronic fatigue syndrome and matched control subjects," BMC Physiol. 2005 Mar 24;5(1):5. PMID: 15790422
Barnden LR, Crouch B, Kwiatek R, Burnet R, Mernone A, Chryssidis S, Scroop G, Del Fante P. "A brain MRI study of chronic fatigue syndrome: evidence of brainstem dysfunction and altered homeostasis." NMR in Biomedicine. published online: 11 MAY 2011
Spitzer AR, Broadman M. "Treatment of the narcoleptiform sleep disorder in chronic fatigue syndrome and fibromyalgia with sodium oxybate." Pain Pract. 2010 Jan-Feb;10(1):54-9. PMID: 20629967
Guilleminault C, Poyares D, Rosa A, Kirisoglu C, Almeida T, Lopes MC. "Chronic fatigue, unrefreshing sleep and nocturnal polysomnography," Sleep Med. 2006 Sep;7(6):513-20. PMID: 16934523
Milhaylova I, et al. Decreased Expression of CD69 in CFS in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells. Neuro Endocrin Lett. 2007 Aug;28(4):477-83. PMID: 17693977
http://chronicfatigue.stanford.edu/
http://www.prohealth.com/library/showarticle.cfm?libid=16320
Ang DC, Moore MN, Hilligoss J, Tabbey R. "MCP-1 and IL-8 as Pain Biomarkers in Fibromyalgia: A Pilot Study." Pain Med. 2011 Jun 30. doi: 10.1111/j.1526-4637.2011.01179.x. [Epub ahead of print] PMID: 21714842
Traynor LM, Thiessen CN, Traynor AP. "Pharmacotherapy of fibromyalgia." Am J Health Syst Pharm. 2011 Jul 15;68(14):1307-19. PMID: 21719591
Staud R. "Sodium oxybate for the treatment of fibromyalgia." Expert Opin Pharmacother. 2011 Jun 16. [Epub ahead of print] PMID: 21679091
Castro-Snchez AM, Matarn-Pearrocha GA, Arroyo-Morales M, Saavedra-Hernndez M, Fernndez-Sola C, Moreno-Lorenzo C. "Effects of myofascial release techniques on pain, physical function, and postural stability in patients with fibromyalgia: a randomized controlled trial." Clin Rehabil. 2011 Jun 14. [Epub ahead of print] PMID: 21673013
Bernardy K, Fuber N, Klose P, Hauser W. "Efficacy of hypnosis/guided imagery in fibromyalgia syndrome - a systematic review and meta-analysis of controlled trials." BMC Musculoskelet Disord. 2011 Jun 15;12(1):133. [Epub ahead of print] PMID: 21676255
RESULTS: Six CTs with 239 subjects with a median of 9 (range 7-12) H/GI-sessions were analysed. [Hypnosis/Guided Imagery] The median number of patients in the H/GI groups was 20 (range 8-26). Three studies performed follow-ups.
H/GI reduced pain compared to controls at final treatment (SMD -1.17 [95% CI -2.21, -0.13]; p= 0.03.
H/GI did not reduce limitations of HRQOL [health-related quality of life] at final treatment (SMD -0.90 [95% CI -2.55, 0.76]; p=0.29) compared to controls.
Effect sizes on fatigue, sleep and depressed mood at final treatment and follow-up and on pain and HRQOL at follow-up were not calculated because of limited data available.
The significant effect on pain at final treatment was associated with low methodological and low treatment quality.
Sorry, but I do not expect hypnotherapy, regression therapy, or similar, to be helpful for ME/CFS or fibromyalgia patients in general.